Home Valeant, Ackman must face U.S. insider trading lawsuit
 

Keywords :   


Valeant, Ackman must face U.S. insider trading lawsuit

2015-11-12 01:40:19| Biotech - Topix.net

A U.S. judge said Valeant Pharmaceuticals International Inc. and activist hedge fund manager William Ackman must face a lawsuit accusing them of insider trading in Allergan Inc before making an unsuccessful takeover bid for the maker of Botox. In a Nov. 9 decision, U.S. District Judge David Carter in Santa Ana, California, rejected arguments by Valeant, Ackman and Ackman's Pershing Square Capital Management that the lawsuit should be dismissed because their activity was not fraudulent.

Tags: face trading insider lawsuit

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
24.11S
24.11
24.115
24.11SR
24.11 RC24.4.5
24.11115+128717dz
24.11lavaSUKALA 3
24.11508A
More »